Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (346)	1/27/1999 1:41:00 PM
From: aknahow	Read Replies (2) \| Respond to of 712

BTW my e - mails to CBS Market Watch and Eisinger did not get sent, but Eisinger apparently saw my post and admits he got the number wrong. Would have liked to see some comment from in a future TSC article. Not to apologize but to set the record straight. Ramp up was great but I also think COR lowballed its' target. Sales were not running at $700,000 the last week of the year. They must have been much higher, giving an average of $700,000 per week for the last quarter. To anyone that communicates with Cor please tell them they don't need a jazzed up web site. Get rid of the images and shockwave and just provide info!